Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS

被引：0
|
作者：
Jones, Rachel [1 ]
Tervaert, Jan Willem Cohen [2 ]
Hauser, Thomas [3 ,4 ]
Luqmani, Raashid [5 ]
Peh, Chen A. U. [6 ]
Savage, Caroline [7 ]
Segelmark, Marten [8 ]
Tesar, Vladimir [9 ]
Van Paassen, Pieter [10 ]
Walsh, Michael [1 ]
Walsh, Dorothy [1 ]
Westman, Kerstin [11 ]
Jayne, David [1 ]
机构：
[1] Addenbrookes Hosp, Vasculitis & Lupus Unit, Cambridge, England
[2] Univ Hosp, Dept Immunol, Maastricht, Netherlands
[3] Univ Zurich Hosp, Dept Immunol, CH-8091 Zurich, Switzerland
[4] Immunol Zentrum, Zurich, Switzerland
[5] Nuffield Orthopaed Ctr, Dept Immunol, Oxford OX3 7LD, England
[6] Royal Adelaide Hosp, Dept Nephrol, Adelaide, SA 5000, Australia
[7] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England
[8] Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden
[9] Charles Univ Prague, Dept Nephrol, Prague, Czech Republic
[10] Univ Hosp, Dept Clin Immunol, Maastricht, Netherlands
[11] Univ Hosp MAS, Dept Nephrol, Malmo, Sweden
来源：
APMIS | 2009年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis
    Nossent, Johannes C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 2072 - 2072
  • [2] Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitis
    Mahajan, Arjun
    Viola, Martin
    Ellen, Jacob
    Piette, Evan W.
    LaChance, Avery H.
    Sparks, Jeffrey A.
    RHEUMATOLOGY, 2025,
  • [3] Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
    Geetha, Duvuru
    Specks, Ulrich
    Stone, John H.
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Fessler, Barri J.
    Ding, Linna
    Tchao, Nadia K.
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Fervenza, Fernando C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (04): : 976 - 985
  • [4] Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
    Jones, Rachel B.
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Morgan, Matthew D.
    Peh, Chen Au
    Savage, Caroline O.
    Segelmark, Marten
    Tesar, Vladimir
    van Paassen, Pieter
    Walsh, Dorothy
    Walsh, Michael
    Westman, Kerstin
    Jayne, David R. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 211 - 220
  • [5] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (04): : 168 - 168
  • [6] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [7] ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
    van Dam, Laura
    Dirikgil, Ebru
    Bredewold, Edwin
    Ray, Argho
    Rabelink, Ton
    van Kooten, Cees
    Teng, Onno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
    Jones, Rachel B.
    Furuta, Shunsuke
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Morgan, Matthew D.
    Peh, Chen Au
    Savage, Caroline O.
    Segelmark, Marten
    Tesar, Vladimir
    van Paassen, Pieter
    Walsh, Michael
    Westman, Kerstin
    Jayne, David R. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1178 - 1182
  • [9] RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY
    Von Allwoerden, K.
    Klapa, S.
    Werth, S. C.
    Mueller, A.
    Riemekasten, G.
    Nitschke, M.
    Thaci, D.
    Lamprecht, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 912 - 913
  • [10] Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial
    Miloslavsky, Eli
    Specks, Ulrich
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert F.
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Tchao, Nadia
    Ding, Linna
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Stone, John H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1190 - S1190
12345